As AstraZeneca puts its COVID-19 vaccine study on hold, experts say don’t worry, just wait
By
Kimberly Marselas
Sep 09, 2020
A vaccine participant in the United Kingdom developed a rare inflammatory disease, causing AstraZeneca to pause its Phase 3 COVID-19 trials.
‘Out in the cold’: LTC pharmacies ask to be matched with vaccination sites, relief funds
By
Alicia Lasek
Dec 22, 2020
As their businesses groan under the weight of COVID-19-related expenses, long-term care pharmacists are pressing federal officials for relief funds and asking for a bigger role in coronavirus vaccinations.
New ‘weapon in our arsenal’: Antibody drug cuts COVID risk by 80 percent in LTC residents
By
Alicia Lasek
Jan 22, 2021
Staff and residents who received Eli Lilly’s monoclonal antibody therapy were less likely to contract symptomatic COVID-19 than placebo groups in a late-stage trial. Industry advocates are hailing...
CDC Shortens Recommended COVID Isolation Period
Mar 01, 2024
New guidance issued Friday by the U.S. Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days.
CMS update for long-term care: J&J vaccine interruption and signs of rare clotting
By
Alicia Lasek
Apr 20, 2021
Concerned LTCF staff members and residents should be aware that cases of blood clots after vaccination appear to be “extremely rare,” CMS says. Nevertheless, the agency is encouraging healthcare...
The coronavirus likely began to spread worldwide last year, say researchers
By
Alicia Lasek
May 06, 2020
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
LED lighting overhaul led to 43 percent falls reduction, Harvard study finds
By
Alicia Lasek
Aug 12, 2022
Resident falls in two long-term care facilities dropped by 43% after the installation of a dynamic lighting program tuned to natural sleep and wake rhythms.
Eliminating residents’ chronic pain not a realistic goal: Aim for quality of life, experts tell...
By
Alicia Lasek
Jun 24, 2021
Even the best, multimodal treatment strategies may be only 30% effective, say the authors of a new review and pain management guide.
COVID-19 vaccine booster jab has 96 percent efficacy, Pfizer reveals
By
Alicia Lasek
Oct 22, 2021
A third dose of Pfizer-BioNTech’s vaccine restores protection against the disease to levels achieved after the second dose, a large new trial shows.
Rollout of COVID antibody therapy requires clinician feedback, U.S. officials say
By
Alicia Lasek
Nov 11, 2020
Federal agencies say they will depend on clinician input during distribution of Eli Lilly’s new intravenous antibody therapy for high-risk COVID-19 patients.